Tryptophan Fluorescence in Hexapeptides
A R T I C L E S
tophan side chain.14,15 There are six low-energy canonical
conformations dictated by the torsional angles about the CR-
Câ (ø1 ) (60°, 180°) and Câ-Cγ (ø2 ) (90°) bonds. If prox-
imity of the indole ring to water or quenching functional groups
differs among rotamers, those rotamers will have different
fluorescence lifetimes. If interconversion among rotamers is
slower than the fluorescence time scale, the fluorescence decay
will be multiexponential with relative amplitudes proportional
to the rotamer populations. For small peptides in solution or
bound to membrane vesicles, several groups have proposed that
the two or three fluorescence decay components represent ø1
rotamers.16-19 The three decay amplitudes of [Trp2]oxytocin
were correlated with ø1 rotamer populations determined by 1H
NMR.20 In addition to rotamers of the tryptophan side chain,
microconformational states of peptides and proteins with
different local environments of the indole ring constitute a source
of ground-state heterogeneity. Finally, relaxation of the protein
matrix surrounding the indole ring during the lifetime of the
excited state would also produce a complex decay.
This contribution tests the rotamer model in a cyclic hexapep-
tide containing a single tryptophan and five other amino acids
whose side chains do not quench 3-methylindole fluorescence.
The cyclic peptide is closely related to a somatostatin analogue
previously shown to have a rigid backbone in organic solvent.21
The solution structure of the cyclic peptide in aqueous solution
is determined by 1D- and 2D-1H NMR. The tryptophan
fluorescence is characterized by steady-state and time-resolved
techniques, and the dependence on solvent isotope and tem-
perature is determined. Fluorescence decay amplitudes are
correlated with the NMR-determined ø1 rotamer populations of
the tryptophan side chain. Excited-state electron-transfer rates
for intramolecular quenching of the six ø1, ø2 rotamers by the
peptide bonds are calculated from Marcus theory using distances
estimated by molecular modeling and parameters estimated from
the electron-transfer rate of N-acetyltryptophanamide (NATA).
The fluorescence lifetimes of the six rotamers are calculated
using these electron-transfer rates together with experimental
values for the intersystem-crossing and water-quenching rates
previously determined for NATA.7 The observed fluorescence
decay is interpreted in terms of the ø1 rotamer populations and
the calculated ø1, ø2 rotamer lifetimes.
was purchased from Perceptive Biosystems. All other reagents and
solvents were highest grade available.
Synthesis. Peptides were synthesized manually using oxime resin
at 25 °C.23 The oxime resin offers two advantages for the synthesis of
small cyclic peptides containing tryptophan: simultaneous cyclization
and cleavage from the resin under mild conditions and efficient isolation
from multimeric side products.22,23 The disadvantage of using Boc resins
is that the repetitive trifluoroacetic acid (TFA) deprotection may result
in modification of peptide side chains. The extent of cyclization using
the oxime resin is highly sequence-dependent.24 Therefore, the amino
acid that was coupled to the resin was permuted in the sequence c[D-
PpYTFWF] except for D-Pro1 and pTyr2 (phosphotyrosine, pY). The
synthesis starting with Thr3 gave the best overall yield of purified
peptide. Thr (3 mmol) was coupled to 1 g of resin (substitution level
0.3-0.5 mmol/g) using 0.35 mM diisopropylcarbodiimide in 6 mL of
CH2Cl2 for 24 h. The solvent was removed, and unreacted sites on the
oxime resin were capped by addition of 6 mL of dry dimethylformamide
(DMF) containing 0.2 M acetic or trimethylacetic anhydride and 0.3
M diisopropylethylamine (DIEA). The coupled amino acid was
deprotected with 25% TFA in 4-6 mL of CH2Cl2 for 15-20 min.
Amino acid coupling reactions were carried out by shaking at room
temperature for 45 min in 6 mL of dry DMF containing 0.25 M HBTU,
0.1 M HOBT, and 0.5 M DIEA, except for D-Pro where HATU replaced
HBTU. The extent of coupling was monitored by a ninhydrin color
test on a small aliquot of resin after each step.25 After the last
deprotection, the peptide was cyclized and cleaved from the resin by
reaction for 48 h with 0.5 M acetic acid and 1.5 M triethylamine in
6-8 mL of dry DMF.26 For c[D-PpYTFWF] and c[D-PpYTFLF], the
organic phase was removed by filtration and added dropwise to cold
diethyl ether, and the white precipitate was removed by centrifugation.
Alternatively, the DMF was removed by vacuum distillation, which
gave a viscous orange residue. For c[D-PFTK(z)WF] and c[D-PFTFWK-
(z)], the organic layer was added dropwise to cold water, and the white
precipitate was removed by centrifugation. The resulting pellet or
residue was dissolved in a small volume of 1:1 CH3CN/H2O and
purified by RP-HPLC on a Vydac C-18 semi-prep column using a
gradient of CH3CN/0.1% TFA: 20-55% for 60 min for c[D-Pp-
YTFWF] and 40-100% for 40 min for the other peptides.
Deprotection of the ꢀ-amino group of lysine was done by catalytic
hydrogenation. The peptide was dissolved in a minimal volume (5-
10 mL) of glacial acetic acid and placed in a hydrogenation flask. A
catalytic amount of 10% Pd on carbon was added, and the suspension
was purged with argon three times and then charged to 50 psi with
hydrogen and shaken overnight. After the hydrogenation was complete,
the Pd catalyst was filtered off, and the flask was washed five times
with small aliquots of ethyl acetate. The ethyl acetate/acetic acid solvent
was removed under vacuum to yield the crude, yellow deprotected
peptide. The peptides were purified by HPLC using a gradient of 20-
55% CH3CN/0.1% TFA for 60 min.
Peptide molecular weights were verified by MALDI-MS. Yields of
purified peptide were 8-17% relative to the substitution level of the
oxime resin. The low yields are probably due to TFA-mediated side
chain reactions or cleavage of the linear sequence during the cyclization
step.
Experimental Section
Materials. Oxime resin was either purchased from Novabiochem
or synthesized.22 N-R-t-Boc-D-proline, -L-phenylalanine, -L-tryptophan,
-L-threonine, and -L-leucine, N-R-t-Boc-N-ꢀ-benzyloxycarbonyl-L-lysine,
2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophos-
phate (HBTU), and N-hydroxybenzotriazole‚H2O (HOBT) were pur-
chased from Novabiochem. N-R-t-Boc-L-phosphotyrosine‚diisopropyl-
ethylamine was purchased from Advanced Chemtech. O-(7-azaben-
zotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HATU)
1H Nuclear Magnetic Resonance. All NMR experiments were
performed using a Varian Inova 600 MHz spectrometer. For experi-
ments in H2O, 2 mg of peptide was dissolved in 600 µL of 10 mM
phosphate buffer, 1 mM NaN3, 10% D2O and pH was adjusted to 3-5
with dilute HCl. Chemical shifts were referenced to 3-(trimethylsilyl)-
propanate-2,2,3,3-d4 (TSP). For experiments in 100% D2O, 1 mg of
(14) Donzel, B.; Gauduchon, P.; Wahl, P. J. Am. Chem. Soc. 1974, 96, 801-
808.
(15) Szabo, A. G.; Rayner, D. M. J. Am. Chem. Soc. 1980, 102, 554-563.
(16) Willis, K. J.; Szabo, A. G. Biochemistry 1992, 31, 8924-8931.
(17) Willis, K. J.; Neugebauer, W.; Sikorska, M.; Szabo, A. G. Biophys. J. 1994,
66, 1623-1630.
(18) Dahms, T. E. S.; Willis, K. J.; Szabo, A. G. J. Am. Chem. Soc. 1995, 117,
2321-2326.
(23) Osapay, G.; Bouvier, M.; Taylor, J. W. Technol. Protein Chem. 2 1991,
221-231.
(19) Clayton, A. H.; Sawyer, W. H. Biophys. J. 1999, 76, 3235-3242.
(20) Ross, J. B. A.; Wyssbrod, H. R.; Porter, R. A.; Schwartz, G. P.; Michaels,
C. A.; Laws, W. R. Biochemistry 1992, 31, 1585-1594.
(21) Kessler, H.; Bats, J. W.; Griesinger, C.; Koll, S.; Will, M.; Wagner, K. J.
Am. Chem. Soc. 1988, 110, 1033-1049.
(24) Nishino, N.; Xu, M.; Mihara, H.; Fujimoto, T. Tetrahedron Lett. 1992, 33,
1479-1482.
(25) Kaiser, E. T.; Colescott, R. L.; Bossinger, C. D.; Cook, P. I. Anal. Biochem.
1970, 34, 595-598.
(22) DeGrado, W. F.; Kaiser, E. T. J. Org. Chem. 1980, 45, 1295-1300.
(26) Gisin, B. F.; Merrifield, R. B. J. Am. Chem. Soc. 1972, 94, 3102-3106.
9
J. AM. CHEM. SOC. VOL. 124, NO. 31, 2002 9279